Global comparator data signal “alarm bells” for UK Government, says APBI
pharmaphorum
JULY 27, 2022
“While we have great strengths and enormous potential to grow life sciences in this country, we are falling behind our global competitors when it comes to crucial areas like the use of diagnostics, patient uptake of new medicines, recruitment to clinical trials, and pharmaceutical exports,” he told pharmaphorum. Access to medicines.
88 
Let's personalize your content